Neurotrack is a digital health company on a mission to transform the diagnosis and management of dementia and Alzheimer’s disease. The company develops clinically-validated cognitive assessments, including the first ever three-minute digital screening to detect cognitive impairment during annual wellness visits. The company also provides patient education and behavioral health support to address modifiable risk factors.